Archive: Healthcare

Charging Patients More Upfront Leads to More Affordable Healthcare
More skin in the game means lower costs for consumers and eventually taxpayers via lower federal health program costs.
Ross Marchand | May 15, 2019
Nurse Practitioners Can Reduce Health Care Costs and Expand Access
If Government Will Allow It
If we used Nurse Practitioners to their full ability, we could meet patients’ health care needs while increasing access.
Conor Norris | May 9, 2019
State Flexibility Is Key to Improving Medicaid
With greater experimentation, states can turn around Medicaid’s lackluster outcomes and help millions of beneficiaries lead better lives.
Ross Marchand | April 26, 2019
Choice and Markets Are Keys to Healthy Living
It’ll take a thriving marketplace of ideas and innovation to make America and the rest of the world a healthier place.
Ross Marchand | April 10, 2019
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Although much work remains to reverse the DEA’s overzealous scheduling system, Ketamine-based treatment for mental illness is another step in the right direction.
Raymond J. March | April 7, 2019
Market-Based Medicine Beats Grim Prognosis
America may have a dysfunctional healthcare system, but at least there’s a glimmer of hope for taxpayers and consumers.
Ross Marchand | April 2, 2019
Healthcare Needs Price Competition, Not Just Transparency
Efforts to make healthcare costs more transparent are a good start. But transparency is no substitute for competition.
Raymond J. March | March 28, 2019
War on Cancer Progress Depends on Market Innovation
The private sector tends to do a better job of finding the “sweet spot” for research spending, leading to blockbuster new drugs and innovation.
Ross Marchand | March 23, 2019
Regulation, Regulation, Regulationception
If lawmakers are truly concerned with out of control drug prices, it isn’t price controls or fines on businesses that will lower them.
Elliot Young | March 7, 2019
Competition is the Key to Reducing Insulin Prices
Not More Government Involvement
Evidence suggests that competition, not politicians, would provide the best chance to help diabetics obtain their life-prolonging medication.
Raymond J. March | March 1, 2019